Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Anne Marie Schjerning Olsen"'
Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study
Autor:
Kristian Kragholm, Christian Torp-Pedersen, Lars Køber, Gunnar Hilmar Gislason, Jannik Pallisgaard, Patricia McGettigan, Gethin Hodges, Anne-Marie Schjerning Olsen, Mikkel Andersen, Maria Krogager, Casper N Bang
Publikováno v:
BMJ Open, Vol 10, Iss 12 (2020)
Objective To evaluate the association between common biomarkers, death and intensive care unit (ICU) admission in patients with COVID-19.Design Retrospective cohort study. From electronic national registry data, we used Cox analysis and bootstrapping
Externí odkaz:
https://doaj.org/article/1019f8aea3ae42c48240b809b87f80a6
Autor:
Gunnar Hilmar Gislason, Jonas Bille Nielsen, Claus Graff, Kristian Hay Kragholm, Adrian Holger Pietersen, Bhupendar Tayal, Christian Selmer, Magnus Kihlstrom, Anne-Marie Schjerning Olsen, Anders G Holst, Peter Søgaard, Christine Benn Christiansen, Steen M Hansen
Publikováno v:
BMJ Open, Vol 9, Iss 6 (2019)
ObjectiveThe objective of the present study was to investigate associations of both overt and subclinical thyroid dysfunction with common ECG parameters in a large primary healthcare population.DesignCross-sectional study.Setting and participantsThe
Externí odkaz:
https://doaj.org/article/26ff3e92d8ab4331aa7666595c294170
Autor:
Mette Nygaard Andersen, Anne-Marie Schjerning Olsen, Jesper Clausager Madsen, Jens Faber, Christian Torp-Pedersen, Gunnar Hilmar Gislason, Christian Selmer
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129793 (2015)
Subclinical hypothyroidism is associated with a number of cardiovascular risk factors, yet only limited data exist on long-term outcome of levothyroxine treatment of this condition with respect to hard end-points. The aim of this retrospective cohort
Externí odkaz:
https://doaj.org/article/0dd4764ec10740cf84ce50f48f0d3f5f
Autor:
Christian Torp-Pedersen, Jesper Lindhardsen, Morten Lamberts, Gunnar Gislason, Patricia McGettigan, Emil L. Fosbøl, Anne-Marie Schjerning Olsen, C A Barcella
Publikováno v:
Barcella, C A, Lamberts, M, McGettigan, P, Fosbøl, E L, Lindhardsen, J, Torp-Pedersen, C, Gislason, G H & Olsen, A-M S 2019, ' Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-a nationwide study in patients with osteoarthritis ', Basic & Clinical Pharmacology & Toxicology, vol. 124, no. 5, pp. 629-641 . https://doi.org/10.1111/bcpt.13182
Barcella, C A, Lamberts, M, McGettigan, P, Fosbøl, E L, Lindhardsen, J, Torp-Pedersen, C, Gislason, G H & Olsen, A-M S 2019, ' Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis ', Basic & Clinical Pharmacology & Toxicology, vol. 124, no. 5, pp. 629-641 . https://doi.org/10.1111/bcpt.13182
Barcella, C A, Lamberts, M, McGettigan, P, Fosbøl, E L, Lindhardsen, J, Torp-Pedersen, C, Gislason, G H & Olsen, A-M S 2019, ' Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis ', Basic & Clinical Pharmacology & Toxicology, vol. 124, no. 5, pp. 629-641 . https://doi.org/10.1111/bcpt.13182
Osteoarthritis (OA) and the non-steroidal anti-inflammatory drugs (NSAIDs) used to relieve OA-associated pain have been linked independently to increased cardiovascular risk. We examined the risk of cardiovascular events associated with NSAID use in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c21b59de95db55530a37cc070bdf293d
https://doi.org/10.1111/bcpt.13182
https://doi.org/10.1111/bcpt.13182
Autor:
Christian Selmer, Morten Lock Hansen, Jonas Bjerring Olesen, Charlotte Mérie, Jesper Lindhardsen, Anne-Marie Schjerning Olsen, Jesper Clausager Madsen, Ulla Schmidt, Jens Faber, Peter Riis Hansen, Ole Dyg Pedersen, Christian Torp-Pedersen, Gunnar Hilmar Gislason
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57893 (2013)
AimsTo examine the long-term risk of hyperthyroidism in patients admitted to hospital with new-onset AF. Hyperthyroidism is a well-known risk factor for atrial fibrillation (AF), but it is unknown whether new-onset AF predicts later-occurring hyperth
Externí odkaz:
https://doaj.org/article/fbc592ed03a54e2e9acb304fc519a879
Autor:
Anne-Marie Schjerning Olsen, Emil L Fosbøl, Jesper Lindhardsen, Charlotte Andersson, Fredrik Folke, Mia B Nielsen, Lars Køber, Peter R Hansen, Christian Torp-Pedersen, Gunnar H Gislason
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54309 (2013)
BackgroundNon steroidal anti-inflammatory drugs (NSAIDs) increase mortality and morbidity after myocardial infarction (MI). We examined cause-specific mortality and morbidity associated with NSAIDs in a nationwide cohort of MI patients.Methods and re
Externí odkaz:
https://doaj.org/article/1bccdda5e8bf48048886b1455dc00556
Autor:
Morten Lamberts, Gunnar Gislason, Morten Lock Hansen, Laila Staerk, Christian Torp-Pedersen, Lars Køber, Anne-Marie Schjerning Olsen, Jannik Langtved Pallisgaard, Caroline Sindet-Pedersen, Emil L. Fosbøl, Jonas Bjerring Olesen, Thomas A. Gerds, Patricia McGettigan
Publikováno v:
Schjerning Olsen, A-M, McGettigan, P, Gerds, T A, Fosbøl, E L, Olesen, J B, Sindet-Pedersen, C, Staerk, L, Hansen, M L, Pallisgaard, J L, Køber, L, Torp-Pedersen, C, Gislason, G H & Lamberts, M 2020, ' Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation : a nationwide study ', European heart journal. Cardiovascular pharmacotherapy, vol. 6, no. 5, pp. 292-300 . https://doi.org/10.1093/ehjcvp/pvz069
Schjerning Olsen, A-M, McGettigan, P, Gerds, T A, Fosbøl, E L, Olesen, J B, Sindet-Pedersen, C, Staerk, L, Hansen, M L, Pallisgaard, J L, Køber, L, Torp-Pedersen, C, Gislason, G H & Lamberts, M 2020, ' Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation : a nationwide study ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 6, no. 5, pp. 292-300 . https://doi.org/10.1093/ehjcvp/pvz069
Schjerning Olsen, A-M, McGettigan, P, Gerds, T A, Fosbøl, E L, Olesen, J B, Sindet-Pedersen, C, Staerk, L, Hansen, M L, Pallisgaard, J L, Køber, L, Torp-Pedersen, C, Gislason, G H & Lamberts, M 2020, ' Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation : a nationwide study ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 6, no. 5, pp. 292-300 . https://doi.org/10.1093/ehjcvp/pvz069
Aims Non-vitamin K antagonist oral anticoagulants (NOACs) are displacing vitamin K antagonists (VKAs) for stroke prophylaxis in patients with atrial fibrillation (AF). Concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) could increase g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05e367f0a016d94808f7d122d78065da
https://vbn.aau.dk/ws/files/315357792/pvz069.pdf
https://vbn.aau.dk/ws/files/315357792/pvz069.pdf
Autor:
Mikkel Meyer Andersen, Lars Køber, Kristian Kragholm, Christian Torp-Pedersen, Gunnar Gislason, Maria Lukács Krogager, Gethin Hodges, Anne-Marie Schjerning Olsen, Jannik Langtved Pallisgaard, Casper N. Bang, Patricia McGettigan
Publikováno v:
Hodges, G, Pallisgaard, J, Schjerning Olsen, A M, McGettigan, P, Andersen, M, Krogager, M, Kragholm, K, Køber, L, Gislason, G H, Torp-Pedersen, C & Bang, C N 2020, ' Association between biomarkers and COVID-19 severity and mortality : A nationwide Danish cohortstudy ', BMJ Open, vol. 10, no. 12, e041295 . https://doi.org/10.1136/bmjopen-2020-041295
BMJ Open, Vol 10, Iss 12 (2020)
Hodges, G, Pallisgaard, J, Schjerning Olsen, A-M, McGettigan, P, Andersen, M, Krogager, M, Kragholm, K, Køber, L, Gislason, G H, Torp-Pedersen, C & Bang, C N 2020, ' Association between biomarkers and COVID-19 severity and mortality : a nationwide Danish cohort study ', BMJ Open, vol. 10, no. 12, e041295 . https://doi.org/10.1136/bmjopen-2020-041295
BMJ Open
Hodges, G, Pallisgaard, J, Schjerning Olsen, A M, McGettigan, P, Andersen, M, Krogager, M, Kragholm, K, Køber, L, Gislason, G H, Torp-Pedersen, C & Bang, C N 2020, ' Association between biomarkers and COVID-19 severity and mortality : a nationwide Danish cohort study ', BMJ Open, vol. 10, no. 12, e041295 . https://doi.org/10.1136/bmjopen-2020-041295
BMJ Open, Vol 10, Iss 12 (2020)
Hodges, G, Pallisgaard, J, Schjerning Olsen, A-M, McGettigan, P, Andersen, M, Krogager, M, Kragholm, K, Køber, L, Gislason, G H, Torp-Pedersen, C & Bang, C N 2020, ' Association between biomarkers and COVID-19 severity and mortality : a nationwide Danish cohort study ', BMJ Open, vol. 10, no. 12, e041295 . https://doi.org/10.1136/bmjopen-2020-041295
BMJ Open
Hodges, G, Pallisgaard, J, Schjerning Olsen, A M, McGettigan, P, Andersen, M, Krogager, M, Kragholm, K, Køber, L, Gislason, G H, Torp-Pedersen, C & Bang, C N 2020, ' Association between biomarkers and COVID-19 severity and mortality : a nationwide Danish cohort study ', BMJ Open, vol. 10, no. 12, e041295 . https://doi.org/10.1136/bmjopen-2020-041295
ObjectiveTo evaluate the association between common biomarkers, death and intensive care unit (ICU) admission in patients with COVID-19.DesignRetrospective cohort study. From electronic national registry data, we used Cox analysis and bootstrapping t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54bedcc347862d18e28938799d54e76
https://curis.ku.dk/portal/da/publications/association-between-biomarkers-and-covid19-severity-and-mortality(cde2a572-97b3-49c1-88e9-38528cac11f8).html
https://curis.ku.dk/portal/da/publications/association-between-biomarkers-and-covid19-severity-and-mortality(cde2a572-97b3-49c1-88e9-38528cac11f8).html
Autor:
Anna Deleskog, Morten Lock Hansen, Anne Marie Schjerning Olsen, Cengiz Özcan, Helene Nordahl Christensen, Gunnar Gislason
Publikováno v:
European Heart Journal — Cardiovascular Pharmacotherapy
Özcan, C, Deleskog, A, Schjerning Olsen, A-M, Nordahl Christensen, H, Lock Hansen, M & Hilmar Gislason, G 2018, ' Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction : a Danish nationwide register-based cohort study ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 4, no. 1, pp. 25-35 . https://doi.org/10.1093/ehjcvp/pvx009
Özcan, C, Deleskog, A, Schjerning Olsen, A-M, Nordahl Christensen, H, Lock Hansen, M & Hilmar Gislason, G 2018, ' Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction : a Danish nationwide register-based cohort study ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 4, no. 1, pp. 25-35 . https://doi.org/10.1093/ehjcvp/pvx009
Aim: Long-term prognostic impact of coronary artery disease (CAD) severity in stable post-myocardial infarction (MI) patients is not well known. We examined the impact of CAD severity and co-morbidity on the long-term (1 year and beyond) risk of card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47904070ac8513dc9b6c88f62755c3bb
http://europepmc.org/articles/PMC5843132
http://europepmc.org/articles/PMC5843132
Autor:
Anne-Marie Schjerning Olsen, Basil S. Lewis, Juan Carlos Kaski, Stefan Agewall, Morten Lamberts, Giuseppe M.C. Rosano, Christian Torp-Pedersen, Morten Schmidt, Juan Tamargo, Alexander Niessner, Keld Kjeldsen, Emil L Fosbøll
Publikováno v:
Schmidt, M, Lamberts, M, Olsen, A-M S, Fosbøl, E, Niessner, A, Tamargo, J, Rosano, G, Agewall, S, Kaski, J C, Kjeldsen, K, Lewis, B S & Torp-Pedersen, C 2016, ' Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs : review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology ', European Heart Journal, vol. 37, no. 13, pp. 1015-1023 . https://doi.org/10.1093/eurheartj/ehv505
Schmidt, M, Lamberts, M, Olsen, A-M S, Fosbøll, E, Niessner, A, Tamargo, J, Rosano, G, Agewall, S, Kaski, J C, Kjeldsen, K, Lewis, B S & Torp-Pedersen, C 2016, ' Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs : review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 2, no. 2, pp. 108-118 . https://doi.org/10.1093/ehjcvp/pvv054
Schmidt, M, Lamberts, M, Olsen, A-M S, Fosbøll, E, Niessner, A, Tamargo, J, Rosano, G, Agewall, S, Kaski, J C, Kjeldsen, K, Lewis, B S & Torp-Pedersen, C 2016, ' Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 2, no. 2, pp. 108-118 . https://doi.org/10.1093/ehjcvp/pvv054
Schmidt, M, Lamberts, M, Olsen, A-M S, Fosbøll, E, Niessner, A, Tamargo, J, Rosano, G, Agewall, S, Kaski, J C, Kjeldsen, K, Lewis, B S & Torp-Pedersen, C 2016, ' Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs : review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology ', European Heart Journal, vol. 37, no. 13, pp. 1015-1023 . https://doi.org/10.1093/eurheartj/ehv505
Schmidt, M, Lamberts, M, Olsen, A-M S, Fosbøll, E, Niessner, A, Tamargo, J, Rosano, G, Agewall, S, Kaski, J C, Kjeldsen, K, Lewis, B S & Torp-Pedersen, C 2016, ' Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs : review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 2, no. 2, pp. 108-118 . https://doi.org/10.1093/ehjcvp/pvv054
Schmidt, M, Lamberts, M, Olsen, A-M S, Fosbøll, E, Niessner, A, Tamargo, J, Rosano, G, Agewall, S, Kaski, J C, Kjeldsen, K, Lewis, B S & Torp-Pedersen, C 2016, ' Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 2, no. 2, pp. 108-118 . https://doi.org/10.1093/ehjcvp/pvv054
Schmidt, M, Lamberts, M, Olsen, A-M S, Fosbøll, E, Niessner, A, Tamargo, J, Rosano, G, Agewall, S, Kaski, J C, Kjeldsen, K, Lewis, B S & Torp-Pedersen, C 2016, ' Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs : review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology ', European Heart Journal, vol. 37, no. 13, pp. 1015-1023 . https://doi.org/10.1093/eurheartj/ehv505
Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) have been used in clinical practice for more than a century and are among the most widely used drugs worldwide for the treatment of pain, fever, and inflammation.1,2 For decades, it has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd27b5f0da280450d7f86a6651b1eca
https://doi.org/10.1093/ehjcvp/pvv054
https://doi.org/10.1093/ehjcvp/pvv054